Objective: The objective of this study was to develop a floating in-situ gel system for the stomachspecific oral delivery of cephalexin. Cephalexin, an antibiotic with a narrow absorption window primarily in the proximal areas of the gastrointestinal tract (GIT), requires targeted and sustained release to effectively treat infections like Helicobacter pylori (H. pylori) and urinary tract infections.